ARTICLE
3 October 2018

International Standards Body Encourages Regulatory Clampdown On OTC Leveraged Products

SS
Shearman & Sterling LLP

Contributor

Our success is built on our clients’ success. We have a long and distinguished history of supporting our clients wherever they do business, from major financial centers to emerging and growth markets. We represent many of the world’s leading corporations and major financial institutions, as well as emerging growth companies, governments and state-owned enterprises, often working on ground-breaking, precedent-setting matters. With a deep understanding of our clients' businesses and the industries they operate in, our work is driven by their need for outstanding legal and commercial advice.
On September 19, 2018, the International Organization of Securities Commissions published a report on retail OTC leveraged products, alongside a statement warning retail investors ...
European Union Consumer Protection

On September 19, 2018, the International Organization of Securities Commissions published a report on retail OTC leveraged products, alongside a statement warning retail investors of the risks of investing in illegal or fraudulent binary options. This step at international level follows the temporary prohibition of the marketing, distribution or sale of binary options and the restrictions on the marketing, distribution or sale of CFDs to retail clients introduced in the EU earlier this year, which the U.K. Financial Conduct Authority fully supported.

The report covers rolling spot forex contracts, CFDs and binary options offered and sold on a domestic and cross-border basis by intermediaries to retail investors. The report includes three toolkits providing guidance to IOSCO member jurisdictions on methods for mitigating the harm to retail investors investing in these products.

The first toolkit outlines policy measures and guidance for the regulation of the offer and sale of these products by intermediaries, including leverage limits, pricing methodologies, marketing restrictions and bans. The second toolkit provides guidance on how member jurisdictions could design investor education programs to inform retail investors about the risks of OTC leveraged products and unlicensed entities active in this area. The third toolkit concerns the activities of unlicensed entities, focusing on binary option firms. It discusses the challenges posed by these firms when they offer OTC leveraged products to retail investors and presents effective practices already used in some jurisdictions to mitigate the risks created by firms illegally or fraudulently offering these products.

The toolkits are not binding on IOSCO members. However, IOSCO encourages its members to consider how one or more of the measures could be adopted into their domestic framework to assist in protecting retail investors.

IOSCO's statement provides information about binary options and warns retail investors about the risks presented by these products. The statement also includes links to action taken by regulators across the globe to address the potential harm of binary options.

The report is available at: http://www.iosco.org/library/pubdocs/pdf/IOSCOPD613.pdf, the statement on binary options is available at: http://www.iosco.org/library/pubdocs/pdf/IOSCOPD614.pdf, details of the EU bans are available at: https://finreg.shearman.com/european-securities-and-markets-authority-intends and details of the FCA's statement supporting the EU actions are available at: https://finreg.shearman.com/uk-conduct-regulator-reminds-firms-of-obligations.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More